Intravenous immunoglobulin for Guillain-Barré syndrome.

Background: Guillain-Barré syndrome (GBS) is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin (IVIg) is beneficial in other autoimmune diseases. This is an update of a review first published in 2001 and previously updated in 2003, 2005, 2007, 2010 and 2012.

Intravenous immunoglobulin for Guillain-Barré syndrome.

Background: Guillain-Barré syndrome (GBS) is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin (IVIg) is beneficial in other autoimmune diseases. This is an update of a review first published in 2001 and previously updated in 2003, 2005, 2007 and 2010.

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Background: Chronic inflammatory demyelinating polyradiculoneuropathy is a disease causing progressive or relapsing and remitting weakness and numbness. It is probably due to an autoimmune process. Immunosuppressive or immunomodulatory drugs would be expected to be beneficial.

Intravenous immunoglobulin for Guillain-Barré syndrome.

Background: Guillain-Barré syndrome is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin is beneficial in other autoimmune diseases.

Objectives: We aimed to determine the efficacy of intravenous immunoglobulin for Guillain-Barré syndrome.

Corticosteroids for Guillain-Barré syndrome.

Background: Guillain-Barré syndrome is caused by inflammation of the peripheral nerves, which corticosteroids should benefit.

Objectives: To examine the efficacy of corticosteroids.

Search Strategy: We searched The Cochrane Neuromuscular Disease Group Trials Specialized Register (June 2009), MEDLINE (January 1966 to June 2009) and EMBASE from (January 1980 to June 2009).

A clinical prognostic scoring system for Guillain-Barré syndrome.

Background: Guillain-Barré syndrome (GBS) is an acute post-infectious immune-mediated peripheral neuropathy with a highly variable clinical course and outcome. We aimed to develop and validate a scoring system based on clinical characteristics in the acute phase of GBS to predict outcome at 6 months.

Methods: We studied patients with GBS who were unable to walk independently.

Immunotherapy for Guillain-Barré syndrome: a systematic review.

Guillain-Barré syndrome (GBS) is an acute inflammatory disorder of the peripheral nervous system thought to be due to autoimmunity for which immunotherapy is usually prescribed. To provide the best evidence on which to base clinical practice, we systematically reviewed the results of randomized trials of immunotherapy for GBS. We searched the Cochrane Library, MEDLINE and EMBASE in July 2006 and used the methods of the Cochrane Neuromuscular Disease Group to extract and synthesize data.

Effects of knee joint angle and tilt table incline on force distribution at the feet and supporting straps.

Objective: To investigate the effects of tilt table incline and knee flexion angle on the degree of weight bearing and forces exerted across the supporting straps.

Design: A quantitative and exploratory study to investigate the effects of a mechanical procedure.

Setting: Physiotherapy gymnasium.

Effects of multisensory stimulation in people with Huntington's disease: a randomized controlled pilot study.

Objective: To investigate whether behavioural, motor and physiological responses of individuals with Huntington's disease (HD) to a controlled multisensory environment (MSE) are effective as a therapeutic (sustained effects) or leisure (immediate effects) activity.

Design: Pilot study--a randomized, controlled, two-group design.

Setting: Specialist residential unit for people with mid-late stage HD.

A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses.

Preventing campylobacteriosis depends on a thorough understanding of its epidemiology. We used case-case analysis to compare cases of Campylobacter coli infection with cases of C. jejuni infection, to generate hypotheses for infection from standardized, population-based sentinel surveillance information in England and Wales.